Health Condition 1: null- Esophageal & Gastroesophageal cancer patients who have already received chemoradiation
Conditions
Interventions
None listed
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: We will include all patients who have received chemotherapy at Tata Memorial Hospital concurrently with radical radiotherapy for esophageal and GE junction carcinoma, from January 2011 onwards (to date), whose data has been prospectively entered in a database that has been maintained in the medical oncology department at Tata Memorial Hospital.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective:- To assess the toxicity of weekly Carboplatin and Paclitaxel in combination with radical radiotherapy in patients with esophageal and GE junction cancer. Timepoint: Acute toxicity weekly while on CTRT Then at 6 weeks after completion of CTRT Then every 3 months for first 2 years and At any point in between as needed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives:- 1. Overall survival 2. Progression-free survival 3. Response rate 4. Evaluate factors that affect toxicity. 5. Evaluate factors that affect survival. Timepoint: Yes we will assess mortality at 1 year , 3 years | — |
Countries
India
Contacts
Public ContactDr Vanita Noronha
Tata Memorial Hospital
Outcome results
None listed